186 related articles for article (PubMed ID: 38488952)
1. Towards clinical adherence monitoring of oral endocrine breast cancer therapies by LC-HRMS-method development, validation, comparison of four sample matrices, and proof of concept.
Jacobs CM; Radosa JC; Wagmann L; Zimmermann JSM; Kaya AC; Aygün A; Edel T; Stotz L; Ismaeil M; Solomayer EF; Meyer MR
Anal Bioanal Chem; 2024 May; 416(12):2969-2981. PubMed ID: 38488952
[TBL] [Abstract][Full Text] [Related]
2. Development, validation, and application of a quantitative volumetric absorptive microsampling-based method in finger prick blood by means of LC-HRMS/MS applicable for adherence monitoring of antipsychotics.
Jacobs CM; Wagmann L; Meyer MR
Anal Bioanal Chem; 2021 Mar; 413(6):1729-1737. PubMed ID: 33517479
[TBL] [Abstract][Full Text] [Related]
3. A new dried blood spot LC-MS/MS method for therapeutic drug monitoring of palbociclib, ribociclib, and letrozole in patients with cancer.
Poetto AS; Posocco B; Gagno S; Orleni M; Zanchetta M; Iacuzzi V; Canil G; Buzzo M; Montico M; Guardascione M; Basile D; Pelizzari G; Alberti M; Gerratana L; Puglisi F; Toffoli G
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122985. PubMed ID: 34700133
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of tamoxifen, anastrozole, and letrozole in human plasma and its application to a clinical study.
Beer B; Schubert B; Oberguggenberger A; Meraner V; Hubalek M; Oberacher H
Anal Bioanal Chem; 2010 Oct; 398(4):1791-800. PubMed ID: 20730580
[TBL] [Abstract][Full Text] [Related]
5. Volumetric Absorptive Microsampling as a New Biosampling Tool for Monitoring of Tamoxifen, Endoxifen, 4-OH Tamoxifen and N-Desmethyltamoxifen in Breast Cancer Patients.
Maggadani BP; Harmita ; Haryono SJ; Rinaldi MR; Harahap Y
Drug Des Devel Ther; 2021; 15():2417-2430. PubMed ID: 34113081
[TBL] [Abstract][Full Text] [Related]
6. Hormonal therapies for early breast cancer: systematic review and economic evaluation.
Hind D; Ward S; De Nigris E; Simpson E; Carroll C; Wyld L
Health Technol Assess; 2007 Jul; 11(26):iii-iv, ix-xi, 1-134. PubMed ID: 17610808
[TBL] [Abstract][Full Text] [Related]
7. Closing the gap - development of an analytical methodology using volumetric absorptive microsampling of finger prick blood followed by LC-HRMS/MS for adherence monitoring of antihypertensive drugs.
Jacobs CM; Kunz M; Mahfoud F; Wagmann L; Meyer MR
Anal Bioanal Chem; 2023 Jan; 415(1):167-177. PubMed ID: 36318313
[TBL] [Abstract][Full Text] [Related]
8. Identification of the aromatase inhibitors anastrozole and exemestane in human urine using liquid chromatography/tandem mass spectrometry.
Mareck U; Geyer H; Guddat S; Haenelt N; Koch A; Kohler M; Opfermann G; Thevis M; Schänzer W
Rapid Commun Mass Spectrom; 2006; 20(12):1954-62. PubMed ID: 16715475
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of an UPLC-MS/MS method for the therapeutic drug monitoring of oral anti-hormonal drugs in oncology.
van Nuland M; Venekamp N; de Vries N; de Jong KAM; Rosing H; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Feb; 1106-1107():26-34. PubMed ID: 30639947
[TBL] [Abstract][Full Text] [Related]
10. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic Drug Monitoring of Oral Anti-Hormonal Drugs in Oncology.
Groenland SL; van Nuland M; Verheijen RB; Schellens JHM; Beijnen JH; Huitema ADR; Steeghs N
Clin Pharmacokinet; 2019 Mar; 58(3):299-308. PubMed ID: 29862467
[TBL] [Abstract][Full Text] [Related]
12. Development of a high-performance liquid chromatography method with fluorescence detection for the routine quantification of tamoxifen, endoxifen and 4-hydroxytamoxifen in plasma from breast cancer patients.
Rangel-Méndez JA; Graniel-Sabido MJ; Sánchez-Cruz JF; Moo-Puc R
Biomed Chromatogr; 2019 Apr; 33(4):e4462. PubMed ID: 30536934
[TBL] [Abstract][Full Text] [Related]
13. Measurement of 5- fluorouracil, capecitabine and its metabolite concentrations in blood using volumetric absorptive microsampling technology and LC-MS/MS.
Radovanovic M; Schneider JJ; Shafiei M; Martin JH; Galettis P
J Chromatogr B Analyt Technol Biomed Life Sci; 2022 Jan; 1188():123075. PubMed ID: 34891049
[TBL] [Abstract][Full Text] [Related]
14. Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis.
Giuliano M; Schettini F; Rognoni C; Milani M; Jerusalem G; Bachelot T; De Laurentiis M; Thomas G; De Placido P; Arpino G; De Placido S; Cristofanilli M; Giordano A; Puglisi F; Pistilli B; Prat A; Del Mastro L; Venturini S; Generali D
Lancet Oncol; 2019 Oct; 20(10):1360-1369. PubMed ID: 31494037
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous quantification of four hormone therapy drugs by LC-MS/MS: Clinical applications in breast cancer patients.
Mansour B; Ngo C; Schlemmer D; Robidou P; Blondel J; Marin C; Noé G; Procureur A; Jamelot M; Gligorov J; Salem JE; Zahr N
J Pharm Biomed Anal; 2024 May; 242():116032. PubMed ID: 38367520
[TBL] [Abstract][Full Text] [Related]
16. Evaluation and analytical applicability of a novel volumetric absorptive microsampling strategy for adherence monitoring of antihypertensive drugs by means of LC-HRMS/MS.
Jacobs CM; Kunz M; Mahfoud F; Wagmann L; Meyer MR
Anal Chim Acta; 2021 Dec; 1187():339137. PubMed ID: 34753562
[TBL] [Abstract][Full Text] [Related]
17. Development of a methodology to quantify tamoxifen and endoxifen in breast cancer patients by micellar liquid chromatography and validation according to the ICH guidelines.
Aranda EO; Esteve-Romero J; Rambla-Alegre M; Peris-Vicente J; Bose D
Talanta; 2011 Apr; 84(2):314-8. PubMed ID: 21376950
[TBL] [Abstract][Full Text] [Related]
18. Fast and Adequate Liquid Chromatography-Tandem Mass Spectrometric Determination of Z-endoxifen Serum Levels for Therapeutic Drug Monitoring.
de Krou S; Rosing H; Nuijen B; Schellens JH; Beijnen JH
Ther Drug Monit; 2017 Apr; 39(2):132-137. PubMed ID: 28045782
[TBL] [Abstract][Full Text] [Related]
19. Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapy.
Antunes MV; Raymundo S; de Oliveira V; Staudt DE; Gössling G; Peteffi GP; Biazús JV; Cavalheiro JA; Tre-Hardy M; Capron A; Haufroid V; Wallemacq P; Schwartsmann G; Linden R
Talanta; 2015 Jan; 132():775-84. PubMed ID: 25476377
[TBL] [Abstract][Full Text] [Related]
20. An UPLC-MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers.
Arellano C; Allal B; Goubaa A; Roché H; Chatelut E
J Pharm Biomed Anal; 2014 Nov; 100():254-261. PubMed ID: 25173109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
